&lt;p&gt;Cross-Cultural Adaptation and Reliability Testing of Chinese Version of the Living with Medicines Questionnaire in Elderly Patients with Chronic Diseases&lt;/p&gt;

Wang, Yongli; Krska, Janet; Lin, Beilei; Mei, Yongxia; Katusiime, Barbra; Guo, Yawen; Zhang, Zhenxiang

doi:10.2147/ppa.s275006

Cited by 8 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study used the C-LMQ-3 translated by the team of this study [ 26 ], which consisted of 39 items in eight domains (i.e., relationships with health professionals, practicalities, interferences, effectiveness, side effects, concerns, cost and autonomy, scored at a 5-point scale from strongly agree to strongly disagree). Total LMQ-3 scores range from 39 to 195; higher scores indicate greater burden associated with medicine use.…”

Section: Methodsmentioning

confidence: 99%

“…As indicated from existing studies, the tool exhibits high reliability and effectiveness, and has been employed in numerous nations (e.g., Australia, Belgium, the Netherlands, New Zealand, Qatar and the United Kingdom) [ 22 – 25 ]. Furthermore, the instrument has also been translated and validated for use in an elderly Chinese population- the C-LMQ-3 [ 26 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study

Wang

Jia

et al. 2021

BMC Geriatr

Self Cite

View full text Add to dashboard Cite

Background In the long-term use of multiple medications for elderly patients diagnosed with chronic diseases, medication problems are prominent, which seriously reduces their quality of life. The burden of medications of patients critically affects their medication beliefs, behaviors and disease outcomes. It may be a solution to stress the burden of medications of patients. Its medication issues develops a novel perspective. The present study aimed to exploit the Chinese version of Living with Medicines Questionnaire-3(C-LMQ-3) to quantify the medicines burden of elderly patients diagnosed with chronic diseases in China, and evaluate the relevant demographic characteristics of sub-populations with high medicines burden. Methods The survey was distributed to elderly patients aged ≥ 60 years with chronic disease by using ≥ 5 medicines, C-LMQ-3 scores and domain scores were compared by the characteristics of elderly patients by employing descriptive statistics and performing statistical tests. Results On the whole, 430 responses were analyzed, and the participants were aged between 60 and 91 years, with the average age of 73.57 years (SD: 7.87). Most of the responses were female (61.7 %) with middle school education (38.5 %). Moreover, 54.1 % of the participants lived with spouse only, 16.2 % had both spouse and children, and 10.0 % lived alone. As indicated from regression analysis, higher C-LMQ-3 scores were associated with those who were with low education level, 60–69 years-old, using ≥ 11 medicines, using medicines ≥ 3 times a day, income per month (RMB) ≤ 3000, and who having higher monthly self-paid medication (RMB) ≥ 300 (p < 0.01). Burden was mainly driven by cost-related burden, concerns about medicines, and the lack of autonomy over medicine regimens. Conclusions This study presents the preliminary evidence to elderly patients diagnosed with chronic diseases in mainland China that pay attention to multiple medications burden may help reduce the Drug Related Problems, whereas some elderly patients have a higher burden of medication. Chinese health care providers are required to primarily evaluate and highlight such patients, and formulate relevant intervention strategies to ensure medication adherence and daily medication management of elderly patients with polypharmacy.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study

Wang

Jia

et al. 2021

BMC Geriatr

Self Cite

View full text Add to dashboard Cite

show abstract

“…The degree of burden was categorized as: minimal (39–105), moderate (106–121), and high (122–195). 18 …”

Section: Methodsmentioning

confidence: 99%

Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China

Zheng¹,

Meng²,

Xiao³

et al. 2022

PPA

View full text Add to dashboard Cite

Purpose People living with HIV (PLWHIV) are susceptible to non-communicable diseases (NCDs) because of aging and infections. This means that the number of non-HIV medications increases, along with issues of polypharmacy and medication-related burden. The purpose of this study was to identify the current situation of polypharmacy and medication-related burden among PLWHIV aged 50 and above, as well as the relation between medication-related burden and antiretroviral therapy (ART) adherence. Patients and Methods A cross-sectional study was conducted with 185 participants recruited from two HIV clinics in Yuelu District Center for Disease Control (CDC) and Changsha First Hospital in Hunan, China. Participants filled questionnaires about comorbidities, polypharmacy, medication-related burden, ART adherence and sociodemographic characteristics. Results Among the participants, 40% were receiving polypharmacy, and PLWHIV, who were female ( β = 5.946; 95% CI = 1.354, 10.541), had a lower monthly income ( β = −4.777; 95% CI = −6.923, −2.632), and took more drugs ( β = 2.200; 95% CI = 1.167, 3.233) were more likely to report a higher level of medication-related burden. The score of ART adherence was negatively associated with medication-related burden ( r s = −0.250 p = 0.001). Conclusion The findings suggest that more attention should be paid to the issues of polypharmacy and targeted interventions should be developed to reduce medication-related burden among older PLWHIV.

show abstract

“…Continuous variables are expressed as the mean ± standard deviation (SD), and categorical variables are presented as percentages (n [%]). The content validity of the C-NEQ was evaluated by our expert team including five experts using the four-point scale from 1 (not relevant) to 4 (highly relevant), to assess the content effectiveness index (I-CVI) and scale content effectiveness index (S-CVI) as previously [ 14 ]. Items with I-CVI =1 and S-CVI values > 0.8 were accepted as indicating relevant content.…”

Section: Methodsmentioning

confidence: 99%

Development and initial validation of the Chinese Version of the Noise Exposure Questionnaire (C-NEQ)

et al. 2022

View full text Add to dashboard Cite

Background With a high prevalence of noise-induced hearing loss (NIHL), the noise survey tools for identifying individuals with high risk of NIHL are still limited. This study was aimed to translate and develop a Chinese version of noise exposure questionnaire (C-NEQ), and validate its reliability and reproducibility. Methods This study was conducted from May 2020 to March 2021 in China. The questionnaire was translated from the original NEQ and adapted into Chinese culture using the method according to the International Test Committee. Content validity was evaluated by our expert group. Construct validity and reliability of the C-NEQ was determined through estimating the confirmatory factor analysis and Cronbach’s alpha in a cross-sectional analysis among 641 Chinese speaking adults, respectively. The retest reproducibility of the C-NEQ was analyzed by using the intra-group correlation coefficient (ICC) in a follow-up analysis among 151 participants. Results The C-NEQ comprises ten items covering four domains: occupational, housework, transport and recreational noise exposure. The annual noise exposure (ANE) was calculated as the protocol of original NEQ. A total of 641 adult participants (aged 26.9 ± 10.1 years, 53.4% males) completed the C-NEQ. The average time for completing the C-NEQ was 4.4 ± 3.0 min. Content validity indicated high relevance of the C-NEQ. The confirmatory factor analysis indices illustrated that the items of the C-NEQ were suitable with the data in the study. For the internal reliability, the Cronbach’s α coefficients of the total items and four domains (occupational, housework, transport, and recreational noise exposure) were 0.799, 0.959, 0.837, 0.825, and 0.803, respectively. Among them, 151 participants (aged 36.1 ± 11.1 years, 65.6% males) completed the retest of the C-NEQ 1 month after the first test. The ICC value of total ANEs between the first test and the second test was 0.911 (P < 0.001). Conclusions In this study, we have validated the C-NEQ with adequate reliability and reproducibility for quantifying an individual’s annual daily noise exposure, which provides an effective fast-screen tool for researches and clinics to identify those individuals with high risks of NIHL within the short time duration (no more than five minutes) among Chinese population.

show abstract

<p>Cross-Cultural Adaptation and Reliability Testing of Chinese Version of the Living with Medicines Questionnaire in Elderly Patients with Chronic Diseases</p>

Cited by 8 publications

References 31 publications

Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study

Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study

Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China

Development and initial validation of the Chinese Version of the Noise Exposure Questionnaire (C-NEQ)

Contact Info

Product

Resources

About